Therapeutic agents for machine perfusion of donor organs

Author:

Rzhevskaya O. N.1ORCID,Magilevets V. M.2,Islamgazin R. S.2ORCID,Yaremin B. I.3ORCID,Anosova E. Yu.3ORCID,Balkarov A.  G.4ORCID,Novruzbekov M. S.1ORCID

Affiliation:

1. N.V. Sklifosovsky Research Institute for Emergency Medicine; Department of Transplantology and Artificial Organs of the Scientific and Educational Institute "N.A. Semashko Higher School of Clinical Medicine", Russian University of Medicine; Department of Transplantology and Artificial Organs, N.I. Pirogov Russian National Research Medical University

2. Department of Transplantology and Artificial Organs of the Scientific and Educational Institute "N.A. Semashko Higher School of Clinical Medicine", Russian University of Medicine

3. N.V. Sklifosovsky Research Institute for Emergency Medicine; Department of Transplantology and Artificial Organs, N.I. Pirogov Russian National Research Medical University

4. N.V. Sklifosovsky Research Institute for Emergency Medicine; Department of Transplantology and Artificial Organs, N.I. Pirogov Russian National Research Medical University; Research Institute for Healthcare Organization and Medical Management

Abstract

Background. The urgency of the unmet need for transplant care dictates the necessity to use organs from suboptimal donors. Machine perfusion, which is actively developing at the present time, is designated to solve this problem. The literature presents novel technologies of ex vivo and in vivo machine perfusion of donor organs, which make it possible to improve their functions and perform a successful transplant. The most promising areas of research both in animals and in humans may be identified by reviewing the literature sources on this subject.The aim was to analyze the world experience of using therapeutic agents in machine perfusion of donor organsMaterial and methods: sources from 2015 to 2023 found in PubMed, Google Scholar, eLibrary databasesConclusion. The rapid progress in lung, liver and kidney transplantation has made it possible to use grafts from asystolic donors for patients in urgent need of donor organs. In turn, these advances have also prompted the study of potential therapeutic agents that can be used during perfusion.

Publisher

IPO Association of Transplantologists

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3